These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 19078947)

  • 1. The use of a clinical utility index to compare insomnia compounds: a quantitative basis for benefit-risk assessment.
    Ouellet D; Werth J; Parekh N; Feltner D; McCarthy B; Lalonde RL
    Clin Pharmacol Ther; 2009 Mar; 85(3):277-82. PubMed ID: 19078947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of zolpidem on sleep architecture and its next-morning residual effect in insomniac patients: a randomized crossover comparative study with brotizolam.
    Uchimura N; Nakajima T; Hayash K; Nose I; Hashizume Y; Ohyama T; Habukawa M; Kotorii N; Kuwahara H; Maeda H
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jan; 30(1):22-9. PubMed ID: 16048734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tiagabine increases slow-wave sleep in a dose-dependent fashion without affecting traditional efficacy measures in adults with primary insomnia.
    Walsh JK; Perlis M; Rosenthal M; Krystal A; Jiang J; Roth T
    J Clin Sleep Med; 2006 Jan; 2(1):35-41. PubMed ID: 17557435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A postmarketing surveillance study of zopiclone in insomnia.
    Mahendran R; Chee KT; Peh LH; Wong KE; Lim L
    Singapore Med J; 1994 Aug; 35(4):390-3. PubMed ID: 7899899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tiagabine enhances slow wave sleep and sleep maintenance in primary insomnia.
    Walsh JK; Zammit G; Schweitzer PK; Ondrasik J; Roth T
    Sleep Med; 2006 Mar; 7(2):155-61. PubMed ID: 16260179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging anti-insomnia drugs: tackling sleeplessness and the quality of wake time.
    Wafford KA; Ebert B
    Nat Rev Drug Discov; 2008 Jun; 7(6):530-40. PubMed ID: 18511929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The partial positive allosteric GABA(A) receptor modulator EVT 201 is efficacious and safe in the treatment of adult primary insomnia patients.
    Walsh JK; Thacker S; Knowles LJ; Tasker T; Hunneyball IM
    Sleep Med; 2009 Sep; 10(8):859-64. PubMed ID: 19345644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rebound insomnia induced by abrupt withdrawal of hypnotics in sleep-disturbed rats.
    Hirase M; Ishida T; Kamei C
    Eur J Pharmacol; 2008 Nov; 597(1-3):46-50. PubMed ID: 18789918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose doxepin for the treatment of insomnia: emerging data.
    Goforth HW
    Expert Opin Pharmacother; 2009 Jul; 10(10):1649-55. PubMed ID: 19496739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of zolpidem on cyclic alternating pattern, an objective marker of sleep instability, in Japanese patients with psychophysiological insomnia: a randomized crossover comparative study with placebo.
    Ozone M; Yagi T; Itoh H; Tamura Y; Inoue Y; Uchimura N; Sasaki M; Shimizu T; Terzano MG; Parrino L
    Pharmacopsychiatry; 2008 May; 41(3):106-14. PubMed ID: 18484552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and clinical safety of ramelteon: an evidence-based review.
    Sateia MJ; Kirby-Long P; Taylor JL
    Sleep Med Rev; 2008 Aug; 12(4):319-32. PubMed ID: 18603221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Development of compounds active in insomnia: recent developments and methodological aspects].
    Staner L; Luthringer R; Macher JP
    Rev Neurol (Paris); 2003 Nov; 159(11 Suppl):6S48-55. PubMed ID: 14646800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sublingual zolpidem is more effective than oral zolpidem in initiating early onset of sleep in the post-nap model of transient insomnia: a polysomnographic study.
    Staner L; Eriksson M; Cornette F; Santoro F; Muscat N; Luthinger R; Roth T
    Sleep Med; 2009 Jun; 10(6):616-20. PubMed ID: 18996742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects on sleep stages and microarchitecture of caffeine and its combination with zolpidem or trazodone in healthy volunteers.
    Paterson LM; Nutt DJ; Ivarsson M; Hutson PH; Wilson SJ
    J Psychopharmacol; 2009 Jul; 23(5):487-94. PubMed ID: 19351801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zolpidem extended-release: a single insomnia treatment option for sleep induction and sleep maintenance symptoms.
    Barkin RL
    Am J Ther; 2007; 14(3):299-305. PubMed ID: 17515707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polysomnographic study of intermittent zolpidem treatment in primary sleep maintenance insomnia.
    Parrino L; Smerieri A; Giglia F; Milioli G; De Paolis F; Terzano MG
    Clin Neuropharmacol; 2008; 31(1):40-50. PubMed ID: 18303490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of 2-week treatment with temazepam and diphenhydramine in elderly insomniacs: a randomized, placebo-controlled trial.
    Glass JR; Sproule BA; Herrmann N; Busto UE
    J Clin Psychopharmacol; 2008 Apr; 28(2):182-8. PubMed ID: 18344728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pit (of sleeplessness) and the pendulum (of regulation).
    Bliwise DL
    Sleep Med; 2010 Jan; 11(1):7-8. PubMed ID: 19945339
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy and safety of doxepin 6 mg in a model of transient insomnia.
    Roth T; Heith Durrence H; Jochelson P; Peterson G; Ludington E; Rogowski R; Scharf M; Lankford A
    Sleep Med; 2010 Oct; 11(9):843-7. PubMed ID: 20817598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indiplon: a nonbenzodiazepine sedative-hypnotic for the treatment of insomnia.
    Marrs JC
    Ann Pharmacother; 2008 Jul; 42(7):1070-9. PubMed ID: 18594049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.